Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

“You’re on a chemotherapeutic and your oncologist may say that your dosage is X, while a nephrologist is telling you that the proximal tubules in your kidneys can’t handle it. You’re harming them.” ...

Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...

The medical-grade glove manufacturing plant that was an expansion of Nephron, one of the largest companies in the Midlands, owes Lexington County nearly $1 million in overdue property taxes despite ...

Nephron Pharmaceuticals Corporation in West Columbia, South Carolina, from the air on Wednesday, April 9, 2025. Joshua Boucher jboucher@thestate.com Nephron Pharmaceuticals, one of the largest ...

Nephron Pharmaceuticals, one of the largest employers in Lexington County, has listed its headquarters in West Columbia for sale. The company’s 700,000+ square-foot drug manufacturing facility located ...

LOS ANGELES--(BUSINESS WIRE)--WhiteHawk Capital Partners, LP ("WhiteHawk"), a private credit investment manager focused on asset-based financing solutions, announced it has entered into an agreement ...

A pair of USC Stem Cell mouse studies detail how progenitor cells self-renew, differentiate, and aggregate into early kidney structures, offering insights for the creation of stem cell-based ...

This image could be hung in a gallery, but it started life as a tiny chunk of a woman’s brain. In 2014, a woman undergoing surgery for epilepsy had a tiny chunk of her cerebral cortex removed. This ...

Add Yahoo as a preferred source to see more of our stories on Google. A recent inspection at a South Carolina drug production facility flagged several problems with how the company was producing drugs ...